1. Home
  2. NSLR vs IMRX Comparison

NSLR vs IMRX Comparison

Compare NSLR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NSLR

Neostellar Capital Corp. Common Stock

N/A

Current Price

$10.10

Market Cap

307.4M

Sector

Finance

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$4.82

Market Cap

313.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSLR
IMRX
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.4M
313.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
NSLR
IMRX
Price
$10.10
$4.82
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
220.2K
602.8K
Earning Date
N/A
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
211.25
37.75
EPS
4.58
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.28
$3.86
52 Week High
$12.19
$10.08

Technical Indicators

Market Signals
Indicator
NSLR
IMRX
Relative Strength Index (RSI) 44.16 50.30
Support Level $9.77 $4.82
Resistance Level $11.24 $5.32
Average True Range (ATR) 0.30 0.21
MACD 0.01 -0.03
Stochastic Oscillator 25.93 22.22

Price Performance

Historical Comparison
NSLR
IMRX

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: